Qualitative plasma PCR (AMPLICOR CMV) vs pp65 antigenemia (AG) for monitoring active cytomegalovirus (CMV) infection and pre-emptive ganciclovir therapy after allogeneic peripheral blood stem cell transplantation (Allo-PBT).

被引：0
|
作者：
Solano, C [1 ]
Gutierrez, A [1 ]
Munoz, I [1 ]
Navarro, D [1 ]
Garcia-Clavel, B [1 ]
Teruel, I [1 ]
Gomez, C [1 ]
Gimeno, C [1 ]
Garcia-Conde, J [1 ]
机构：
[1] Univ Valencia, Hosp Clin, Valencia, Spain
来源：
BLOOD | 2001年 / 98卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1658
引用
收藏
页码：394A / 394A
页数：1
相关论文
共 39 条
  • [31] Pre-emptive oral vs. IV ganciclovir therapy against cytomegalovirus disease after allogeneic hematopoietic stem cell transplantation (Hsct) in patients with solid tumor
    Barkholt, L
    Lewensohn-Fuchs, I
    Hentschke, P
    Stahle, L
    Helldén, A
    Ringdén, O
    BONE MARROW TRANSPLANTATION, 2002, 29 : S192 - S192
  • [32] Quantitative real-time PCR compared with pp65 antigen detection for cytomegalovirus (CMV) in 1122 blood specimens from 77 patients after allogeneic stem cell transplantation: Which test better predicts CMV disease development?
    Nitsche, A
    Oswald, O
    Steuer, N
    Schetelig, J
    Radonic, A
    Thulke, S
    Siegert, W
    CLINICAL CHEMISTRY, 2003, 49 (10) : 1683 - 1685
  • [33] Results of a phase I/II British Society of Bone Marrow Transplantation study on PCR-based pre-emptive therapy with valganciclovir or ganciclovir for active CMV infection following alemtuzumab-based reduced intensity allogeneic stem cell transplantation
    Lim, Z. Y.
    Cook, G.
    Johnson, P. R.
    Parker, Anne
    Zuckerman, M.
    Marks, D.
    Wiltshire, H.
    Mufti, G. J.
    Pagliuca, A.
    LEUKEMIA RESEARCH, 2009, 33 (02) : 244 - 249
  • [34] The CMV serostatus of the recipient and the donor is still an important prognostic factor in acute leukaemia patients after allogeneic stem cell transplantation in the era of pre-emptive therapy of CMV infection. A survey on behalf of the ALWP of EBMT
    Schmidt-Hieber, M.
    Labopin, M.
    Beelen, D.
    Volin, L.
    Ehninger, G.
    Finke, J.
    Socie, G.
    Schwerdtfeger, R.
    Kroeger, N.
    Ganser, A.
    Niederwieser, D.
    Polge, E.
    Blau, I.
    Mohty, M.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S18 - S18
  • [35] Lack of prompt expansion of cytomegalovirus pp65 and IE-1-specific IFNγ CD8+ and CD4+ T cells is associated with rising levels of pp65 antigenemia and DNAemia during pre-emptive therapy in allogeneic hematopoietic stem cell transplant recipients
    Tormo, N.
    Solano, C.
    Benet, I.
    Clari, M. A.
    Nieto, J.
    de la Camara, R.
    Lopez, J.
    Lopez-Aldeguer, N.
    Hernandez-Boluda, J. C.
    Remigia, M. J.
    Garcia-Noblejas, A.
    Gimeno, C.
    Navarro, D.
    BONE MARROW TRANSPLANTATION, 2010, 45 (03) : 543 - 549
  • [36] Lack of prompt expansion of cytomegalovirus pp65 and IE-1-specific IFNγ CD8+ and CD4+ T cells is associated with rising levels of pp65 antigenemia and DNAemia during pre-emptive therapy in allogeneic hematopoietic stem cell transplant recipients
    N Tormo
    C Solano
    I Benet
    M A Clari
    J Nieto
    R de la Cámara
    J López
    N López-Aldeguer
    J C Hernández-Boluda
    M J Remigia
    A Garcia-Noblejas
    C Gimeno
    D Navarro
    Bone Marrow Transplantation, 2010, 45 : 543 - 549
  • [37] Once daily intravenous gancyclovir (ODG) as pre-emptive therapy (PT) for cytomegalovirus (CMV) viremia in 200 patients undergoing allogeneic related donor peripheral blood stem cell transplantation (Allo-PBSC) and matched unrelated donor bone marrow transplantation (MUD-BMT).
    Vij, R
    Brown, R
    Adkins, D
    Khoury, H
    Goodnough, LT
    Westervelt, P
    DiPersio, JF
    BLOOD, 1999, 94 (10) : 336A - 336A
  • [38] Human cytomegalovirus immediate-early mRNAemia versus pp65 antigenemia for guiding pre-emptive therapy in children and young adults undergoing hematopoietic stem cell transplantation: a prospective, randomized, open-label trial
    Gerna, G
    Lilleri, D
    Baldanti, F
    Torsellini, M
    Giorgiani, G
    Zecca, M
    De Stefano, P
    Middeldorp, J
    Locatelli, F
    Revello, MG
    BLOOD, 2003, 101 (12) : 5053 - 5060
  • [39] Graft-Vs-Host Disease (GvHD) Prophylaxis with Post-Transplant Cyclophosphamide (PTCy) and Thymoglobulin (ATG) Are More Important Determinants of Cytomegalovirus (CMV) Reactivation after Allogeneic Hematopoietic Cell Transplantation (HCT) Than Ex-Vivo T-Cell Depletion in the Era of Pre-Emptive Therapy
    Chong, Lip Leong
    Chia, Chelsea
    Koh, Yin Teng
    Boo, Yang Liang
    Lee, Chun Tsu
    Poon, Michelle
    Tan, Lip Kun
    Koh, Liang Piu
    BLOOD, 2021, 138
1234